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Background: To study the mineralization capacity in vitro of the bioceramic endodontic material MTA HP Repair.
Material and Methods: Bioactivity evaluation in vitro was carried out, by soaking processed cement disk in simula-
ted body fluid (SBF) during 168 h. The cement surface was studied by Fourier transform infrared spectroscopy (FT-
IR), field emission gun scanning electron microscopy (FEG-SEM) and energy dispersive X-ray analysis (EDX). 
Release to the SBF media of ionic degradation products was monitored using inductively coupled plasma atomic 
emission spectroscopy (ICP-AES).                      
Results: FT-IR showed increasing formation of phosphate phase bands at 1097, 960, 607 and 570 cm-1 with prolon-
ged SBF soaking. FEG-SEM analysis reveals that HP produces a effectively surface covering consisting in homo-
geneous spherical phosphate phase aggregates with an average diameter of 0.5-1.0 µm. EDX analysis comparing 
un-treated (hydrated), 24 h and 72 h SBF treated surfaces of MTA HP Repair revealed phosphate deposition after 24 
h, with high phosphorous/silicon element ratio signal measured after 24 h, indicating a very high phosphate phase 
deposition for this material.  
Conclusions: The study shows that MTA HP Repair produces a quick and effective bioactive response in vitro in 
terms of crystalline calcium phosphate surface coating formation. The high bioactive response of MTA HP Repair 
makes it an interesting candidate for endodontic use as repair cement.




Bioceramic endodontic cements (BECs), such as Mi-
neral Trioxide Aggregate (MTA) and related materials, 
stimulate the natural remineralization process at the ma-
terial-tooth interface (1). Therefore, they are considered 
bioactive endodontic cements (2), being applied as acti-
ve therapeutic agent to stimulate regeneration (3-6). 
Calcium silicates (Ca3SiO5 and Ca2SiO4) are the base 
compounds of BECs, together with radiopacifying ad-
ditives such as bismuth, zirconia, tantalum, or tungsten 
oxides (2,7). Calcium silicate based cements, particular-
ly those containing bismuth oxide as radiopacifier (8), 
present some disadvantages such as tooth discoloration, 
long setting time or difficult handling (9). Consequently, 
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new BECs have been prepared replacing bismuth oxide 
with alternative radiopacifier materials (9,10).  
MTA Repair HP (Angelus, Londrina, Brasil) is a new 
BEC in which, bismuth oxide has been replaced by cal-
cium tungstate (CaWO4) as radiopacifier and this modifi-
cation of cement composition will alter the physico-che-
mical characteristics and the biomechanical properties 
of the bioceramic material (2,11,12), and could also mo-
dify the biological functional properties (2,13,14). The 
aim of this study is to assess the mineralization capacity 
and bioactive response in vitro of the bioceramic endo-
dontic cement MTA HP Repair (HP). 
Material and Methods
MTA HP Repair (Angelus, Londrina, Brasil) was used in 
this study. The composition of the bioceramic as the ma-
nufacturer specifications is: tricalcium silicate (Ca3SiO5), 
dicalcium silicate (Ca2SiO4), calcium tungstate (CaWO4) 
as radiopacifier, tricalcium aluminate (3CaO.Al2O3), and 
calcium oxide (CaO).  
The in vitro bioactivity evaluation was assessed, by soa-
king the cement disks in 13 mL of simulated body fluid 
(SBF) (15) during 4, 24, 72 and 168 h at 36.5 oC and 
60 r.p.m. shaking using polytetrafluoroethylene beakers. 
Previously to the bioactivity assay, the samples were ste-
rilized under UV light for 10 min period on each side. 
SBF solution was filtered using 0.2 mm bacteriostatic 
filter (Biofil). 
Fourier transform infrared (FT-IR) spectra of as-pro-
cessed set material and the SBF treated samples were 
collected in transmission configuration in the 1300-400 
cm-1 range using 4 cm-1 intervals in a Nicolet IS50 FT-
IR (Thermo Scientific, Madison WI, USA). The micros-
tructures were studied by field emission gun scanning 
electron microscopy (FEG-SEM) using a HITACHI 
S-4800 (Tokyo, Japan). Images were recorded at an 
accelerating voltage of 2 kV. Energy dispersive X-ray 
(EDX) analysis was carried out at 10 kV with an EDX 
Bruker XFlash 4010 detector. Concentrations of Si, Ca, 
P, W and Al ions in the soaking media were monitored 
after 72 and 168h by inductively coupled plasma atomic 
emission spectroscopy (ICP-AES) using the spectrome-
ter Horiba Jobin Yvon (Ultima 2, Paris, France). Control 
solutions consisting of pure SBF was simultaneously 
prepared and stored under the same conditions. 
Results
The FT-IR absorbance spectra of MTA HP Repair after 
the analysed SBF treatment times, in comparison with 
the spectra of the as-set (SBF un-treated) sample, are 
shown in Figure 1. An important intensity increase with 
treatment time, of calcium silicate hydrate C-S-H broad 
band within the 1000-1100 cm-1 range is observed. Li-
kewise, increasing formation of phosphate phase bands 
at 1097, 960, 607 and 570 cm-1 (16), are clearly obser-
	
Fig. 1: Fourier transform infrared (FT-IR) spectra of MTA HP 
Repair after SBF treatment of the different analysed times plotted 
together with the spectra of the SBF un-treated samples. (S-C-H = 
calcium silicate hydrate).
ved with prolonged SBF soaking. Calcium hydroxyapa-
tite growing on the MTA HP Repair surface after 72 h 
treatment can be inferred from the two bands at 607 and 
570 cm-1 characteristics of phosphate in a crystalline en-
vironment (17). Incipient signals at 607 and 570 cm-1 are 
observed at only 24 h SBF treatment.
Back-scatter FEG-SEM micrographs of the un-treated 
MTA HP Repair set material surface (a, b), as well as 
secondary images after 24 h (c, d) and 72 h (e, f) SBF 
treatment, at two different magnifications are presented 
in Figure 2. New homogeneous spherical aggregate for-
mations covering the surface of the SBF treated samples 
are observed after 24 h soaking time, showing average 
diameter spheres in the 0.5-1.0 µm range. After 72 h 
SBF treatment, a visible growing in size of the spherical 
features is observed. Besides, prismatic features charac-
teristic of calcium apatite-like structure with hexagonal 
symmetry, growing out of the spherical formations are 
clearly visible in Figure 3. Calcium phosphate deposi-
tion is confirmed by EDX analysis. Un-treated, 24 h and 
72 h SBF treated surfaces of MTA HP Repair are dis-
played in Figure 4. The analysis reveals the detection of 
a high phosphorous signal after only 24 h, indicating a 
very high phosphate phase deposition for this material.  
Si, Ca, P, W and Al ionic product in solution after 72 
and 168 h SBF soaking treatment are presented in Table 
1. Si and Ca, major BEC material components, elution 
indicates material dissolution. W and Al ions were also 
detected in solution being Al particularly high, showing 
up to 0.4 mg L-1 concentration after 168 h. 
Discussion
Calcium phosphate mineralization capacity of MTA HP 
Repair, a bioceramic cement with calcium tungstate as 
radiopacifier used in endodontic therapy, has been stu-
died. Bioactivity assay in vitro indicates that MTA HP 
Repair forms a structured crystallized calcium phospha-
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Fig. 2: Field emission gun scanning electron microscopy (FEG-SEM) of MTA HP Repair. Back- scatter electron 
micrographs of un-treated surfaces (a, b); and secondary electron micrographs after 24 h (c-d) and 72 h (e-f) SBF 





Fig. 3: Field emission gun scanning electron microscopy 
(FEG-SEM) of MTA HP Repair: secondary electron mi-
crograph after 72 h SBF treatment. Scale bar: (2 µm).
	
Fig. 4: Energy dispersive X-ray (EDX) analyses of un-treated and 
after 24 h and 72 h SBF treatment of MTA HP Repair.  
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te coating layer after 72 h treatment. FEG-SEM obser-
vations of MTA HP Repair surface after 24 h only SBF 
treatment, shows a phosphate phase coating formed of 
homogeneous spheres with an average diameter in the 
0.5-1.0 µm range. This high bioactive response might be 
associated to the high calcium aluminate content of this 
Table 1: Si, Ca, P, W and Al ionic product degradation concentration in the SBF soaking media of MTA HP Repair material 
monitored by inductively coupled plasma atomic emission spectroscopy (ICP-AES).
material (18), and to the great surface degradation, as 
measured by the Si and Ca ion product release, detected 
by ICP. The nucleation of the calcium phosphate phase 
would be favoured by the change in the chemical com-
position and in the pH of the solution resulting from the 
accumulation of dissolution products from the MTA HP 
Repair, with the appearance of new surface sites (19). 
Particularly, the repolymerization of a porous silica-rich 
layer through silanol groups condensation from the solu-
ble silica in the form of Si(OH)4, followed by the migra-
tion of Ca2+ and PO4
3- groups to the surface forms a film 
rich in amorphous CaO-P2O5. 
The clinical manifestation of bioactivity with the use of 
BECs has been attributed to phosphate phase’s minera-
lization induction capacity (16) and compared to that 
of calcium hydroxide postulating that the mechanisms 
of action were similar (20). When MTA HP Repair is 
exposed to a phosphate-containing media such as SBF, 
a series of reactions take place on the surface between 
calcium from the cement and phosphate from the solu-
tion consisting of the absorption of Ca and P ions on 
the silica-rich (C-S-H) surface and the precipitation of 
HPO4
2- containing phase which matures into a crystalline 
hydroxycarbonate apatite phase at increasing treatment 
times. Micrograph in Figure 3 displays, resolved elon-
gated nano-metrical grains with crystalline morphology 
growing out of spherical formations, which have been 
confirmed as calcium phosphate composition by FT-IR 
and EDX. We argue that, the new formed calcium phos-
phate layer could filled the superficial crack and voids 
providing a stable sealing at cement surface. Also, that 
phosphate ions able to promote apatite deposition, from 
biological fluids and blood present at the external surfa-
ce during surgical procedures, could well enhance the 
formation of a mineralised biomimetic cement-tissue in-
terphase. A recent investigation carried out by Qiu et al. 
(21) using MTA extract has shown that concentrations of 
Ca ions of 88.9 mg L-1 and Si ions of 0.22 mg L-1 in the 
culture medium promote the repair of injured pulp, po-
tentially by accelerating proliferation and reducing the 
time required for hDPCs to enter into the odontoblastic 
differentiation stage in the clinical setting. 
The results of the present study indicates that MTA HP 
Repair produces a quick and effective bioactive respon-
se in vitro in terms of HA surface coating formation. The 
high bioactivity response for HP is in good accordan-
ce with its high calcium aluminate content. Recently, a 
study carried out on human dental pulp stem cells has 
demonstrated the high biocompatibility and cytocompa-
tibility of MTA Repair HP (7). 
Conclusions
Bioactivity essay in vitro indicates that MTA HP Repair 
produces a quick and effective bioactive response in vi-
tro in terms of homogeneous calcium phosphate surface 
coating formation. MTA HP Repair stimulates the for-
mation of a nanostructured calcium phosphate coating 
layer after 72 h treatment. The high bioactive response 
of MTA HP Repair makes it ideal for endodontic use as 
repair cement.
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